Coherus BioSciences to launch Humira biosimilar at 85% discount
(Reuters) -Coherus BioSciences Inc said on Thursday it plans to launch a biosimilar of AbbVie Inc’s Humira in July at a list price of $995… Read More »Coherus BioSciences to launch Humira biosimilar at 85% discount